Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
The principal changes are as follows: GHK-Cu for non-injectable routes of administration is being removed from Category 1, and GHK-Cu for injectable routes of administration is separately being removed from Category 2
Part D enrollees using a GLP-1 for type 2 diabetes, sleep apnea, or other Medicare-covered uses will continue accessing the drug through their Part D plan and paying their plans cost-sharing requirement, even if its more than the $50 copayment for GLP-1s for obesity under the Medicare GLP-1 Bridge
Manufacturing standards Production in FDA-registered, GMP-certified facilities provides meaningful quality assurance
Secreted by L-cells found in the ileum of the small intestine and the large intestine, GLP-1 plays an important role in the body
US$ 23.26
US$ 23.56
US$ 27.67
US$ 20.66
US$ 24.59
